ImpediMed Limited
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue compositi… Read more
ImpediMed Limited (IPDQF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.390x
Based on the latest financial reports, ImpediMed Limited (IPDQF) has a cash flow conversion efficiency ratio of -0.390x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-8.00 Million) by net assets ($20.50 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ImpediMed Limited - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how ImpediMed Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ImpediMed Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ImpediMed Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NISSAN SECURITIES GROUP
F:OH5
|
N/A |
|
Neffs Bancorp Inc
PINK:NEFB
|
0.075x |
|
Openbase Inc
KQ:049480
|
0.036x |
|
Value8 N.V
AS:VALUE
|
0.007x |
|
Daily Polymer
TWO:4716
|
0.024x |
|
Ramssol Group Bhd
KLSE:0236
|
0.140x |
|
Ten Ren Tea Co Ltd
TW:1233
|
0.036x |
|
B1Q
F:B1Q
|
0.112x |
Annual Cash Flow Conversion Efficiency for ImpediMed Limited (2008–2025)
The table below shows the annual cash flow conversion efficiency of ImpediMed Limited from 2008 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $20.50 Million | $-14.64 Million | -0.715x | -63.65% |
| 2024-06-30 | $40.74 Million | $-17.79 Million | -0.437x | -47.27% |
| 2023-06-30 | $60.88 Million | $-18.05 Million | -0.296x | +3.39% |
| 2022-06-30 | $51.04 Million | $-15.66 Million | -0.307x | +40.94% |
| 2021-06-30 | $25.51 Million | $-13.26 Million | -0.520x | +26.02% |
| 2020-06-30 | $27.36 Million | $-19.22 Million | -0.702x | +43.40% |
| 2019-06-30 | $15.79 Million | $-19.59 Million | -1.241x | -90.45% |
| 2018-06-30 | $36.00 Million | $-23.46 Million | -0.652x | -49.85% |
| 2017-06-30 | $58.80 Million | $-25.57 Million | -0.435x | -65.33% |
| 2016-06-30 | $85.25 Million | $-22.42 Million | -0.263x | +14.83% |
| 2015-06-30 | $34.84 Million | $-10.76 Million | -0.309x | +38.57% |
| 2014-06-30 | $13.53 Million | $-6.80 Million | -0.503x | +30.62% |
| 2013-06-30 | $10.59 Million | $-7.67 Million | -0.724x | -6.30% |
| 2012-06-30 | $17.31 Million | $-11.80 Million | -0.682x | -24.75% |
| 2011-06-30 | $20.68 Million | $-11.30 Million | -0.546x | -16.93% |
| 2010-06-30 | $22.23 Million | $-10.39 Million | -0.467x | +60.09% |
| 2009-06-30 | $10.07 Million | $-11.79 Million | -1.171x | -94.18% |
| 2008-06-30 | $12.30 Million | $-7.42 Million | -0.603x | -- |